Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-10,907
Closed -$447K 397
2023
Q1
$447K Buy
10,907
+2,951
+37% +$123K 0.01% 310
2022
Q4
$276K Buy
+7,956
New +$278K 0.01% 308
2021
Q4
Sell
-12,791
Closed -$530K 318
2021
Q3
$530K Buy
+12,791
New +$510K 0.01% 432
2021
Q2
Sell
-6,857
Closed -$303K 664
2021
Q1
$303K Buy
+6,857
New +$259K ﹤0.01% 436
2019
Q4
Sell
-222,334
Closed -$5.11M 342
2019
Q3
$5.11M Buy
+222,334
New +$5.07M 0.08% 139

Other funds holding ADNT

Lee Ainslie's ADNT Position: Q2 2023 in Review

Lee Ainslie sold out of Adient (ADNT) in Q2 2023, closing a stake of 10,907 shares — an estimated $447K sold.

Lee Ainslie first reported a position in ADNT in Q3 2019 and held it in 5 quarters. The position peaked at $5.11M in Q3 2019. 266 funds tracked by Wall St. Rank hold ADNT as of Q2 2023.

  • Lee Ainslie reported no remaining Adient position as of Q2 2023 after selling out during the quarter.
  • Lee Ainslie sold 10,907 Adient shares in Q2 2023, an estimated $447K.
  • Lee Ainslie first reported a position in Adient in Q3 2019 and held it in 5 quarters.
  • Lee Ainslie's Adient position peaked at $5.11M in Q3 2019.
  • 266 funds tracked by Wall St. Rank held Adient as of Q2 2023.

Based on Maverick Capital's 13F filing for Q2 2023, filed 14 Aug 2023.